HER2-targeted therapy in breast cancer: a systematic review of neoadjuvant trials.

Dent S., Oyan B., Honig A., Mano M., Howell S.

Cancer treatment reviews, cilt.39, ss.622-31, 2013 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.ctrv.2013.01.002
  • Dergi Adı: Cancer treatment reviews
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.622-31
  • Anahtar Kelimeler: Neoadjuvant breast cancer, Pathological complete response, Trastuzumab, Lapatinib, Pertuzumab, Novel agents, HER2, PHASE-II TRIAL, PATHOLOGICAL COMPLETE RESPONSE, CHEMOTHERAPY PLUS TRASTUZUMAB, STAGE-II, OPEN-LABEL, PREOPERATIVE CHEMOTHERAPY, INDUCTION CHEMOTHERAPY, ADJUVANT TRASTUZUMAB, NAB-PACLITAXEL, DOCETAXEL
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır